Smell and taste disorders during COVID‐19 outbreak: Cross‐sectional study on 355 patients
Abstract
As reported by increasing literature, a significant number of patients with SARS‐CoV‐2 infection developed smell/taste disorders. Aim of this study is to determine the prevalence and severity of these symptoms among laboratory‐confirmed SARS‐CoV‐2 patients. Secondary objective is to determine their onset/recovery time.
Read the paper
Related studies
- Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol
- Glucoraphanin: a broccoli sprout extract that ameliorates obesity-induced inflammation and insulin resistance
- SGLT2 Inhibitors in Heart Failure: Targeted Metabolomics and Energetic Metabolism
- Mechanisms of blood pressure reduction with sodium-glucose co-transporter 2 (SGLT2) inhibitors
- Sodium-glucose cotransporter inhibitors: beyond glycaemic control
- Decoding the effects of SGLT2 inhibitors on cardiac arrhythmias in heart failure
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.